Please use this identifier to cite or link to this item:
Title: PAX4 preserves endoplasmic reticulum integrity preventing beta cell degeneration in a mouse model of type 1 diabetes mellitus.
Authors: Mellado-Gil, José Manuel
Jiménez-Moreno, Carmen María
Martin-Montalvo, Alejandro
Alvarez-Mercado, Ana Isabel
Fuente-Martin, Esther
Cobo-Vuilleumier, Nadia
Lorenzo, Petra Isabel
Bru-Tari, Eva
Herrera-Gómez, Irene de Gracia
López-Noriega, Livia
Pérez-Florido, Javier
Santoyo-López, Javier
Spyrantis, Andreas
Meda, Paolo
Boehm, Bernhard O
Quesada, Ivan
Gauthier, Benoit R
Keywords: Beta cell degeneration;ER homeostasis;PAX4;RIP-B7.1;Type 1 diabetes
metadata.dc.subject.mesh: Animals
Cell Proliferation
Diabetes Mellitus, Type 1
Endoplasmic Reticulum
Homeodomain Proteins
Insulin-Secreting Cells
Mice, Mutant Strains
Paired Box Transcription Factors
Issue Date: 26-Jan-2016
Abstract: A strategy to enhance pancreatic islet functional beta cell mass (BCM) while restraining inflammation, through the manipulation of molecular and cellular targets, would provide a means to counteract the deteriorating glycaemic control associated with diabetes mellitus. The aims of the current study were to investigate the therapeutic potential of such a target, the islet-enriched and diabetes-linked transcription factor paired box 4 (PAX4), to restrain experimental autoimmune diabetes (EAD) in the RIP-B7.1 mouse model background and to characterise putative cellular mechanisms associated with preserved BCM. Two groups of RIP-B7.1 mice were genetically engineered to: (1) conditionally express either PAX4 (BPTL) or its diabetes-linked mutant variant R129W (mutBPTL) using doxycycline (DOX); and (2) constitutively express luciferase in beta cells through the use of RIP. Mice were treated or not with DOX, and EAD was induced by immunisation with a murine preproinsulin II cDNA expression plasmid. The development of hyperglycaemia was monitored for up to 4 weeks following immunisation and alterations in the BCM were assessed weekly by non-invasive in vivo bioluminescence intensity (BLI). In parallel, BCM, islet cell proliferation and apoptosis were evaluated by immunocytochemistry. Alterations in PAX4- and PAX4R129W-mediated islet gene expression were investigated by microarray profiling. PAX4 preservation of endoplasmic reticulum (ER) homeostasis was assessed using thapsigargin, electron microscopy and intracellular calcium measurements. PAX4 overexpression blunted EAD, whereas the diabetes-linked mutant variant PAX4R129W did not convey protection. PAX4-expressing islets exhibited reduced insulitis and decreased beta cell apoptosis, correlating with diminished DNA damage and increased islet cell proliferation. Microarray profiling revealed that PAX4 but not PAX4R129W targeted expression of genes implicated in cell cycle and ER homeostasis. Consistent with the latter, islets overexpressing PAX4 were protected against thapsigargin-mediated ER-stress-related apoptosis. Luminal swelling associated with ER stress induced by thapsigargin was rescued in PAX4-overexpressing beta cells, correlating with preserved cytosolic calcium oscillations in response to glucose. In contrast, RNA interference mediated repression of PAX4-sensitised MIN6 cells to thapsigargin cell death. The coordinated regulation of distinct cellular pathways particularly related to ER homeostasis by PAX4 not achieved by the mutant variant PAX4R129W alleviates beta cell degeneration and protects against diabetes mellitus. The raw data for the RNA microarray described herein are accessible in the Gene Expression Omnibus database under accession number GSE62846.
metadata.dc.identifier.doi: 10.1007/s00125-016-3864-0
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC4779135.pdf2,03 MBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons